Refractory hypertension is associated with a high prevalence of target organ damage, highlighting the need for intensive therapeutic approaches to normalize blood pressure.
Our study suggests that RH is a clinical condition associated with a high prevalence of TOD at cardiac, macro- and microvascular level and consequently with high absolute cardiovascular risk, which needs a particularly intensive therapeutic approach aimed to normalize BP levels and to induce TOD regression.
Cuspidi et al. (Thu,) studied this question.